148 related articles for article (PubMed ID: 31521819)
1. Pharmacological approaches to tackle NCLs.
Kauss V; Dambrova M; Medina DL
Biochim Biophys Acta Mol Basis Dis; 2020 Sep; 1866(9):165553. PubMed ID: 31521819
[TBL] [Abstract][Full Text] [Related]
2. Current and Emerging Treatment Strategies for Neuronal Ceroid Lipofuscinoses.
Kohlschütter A; Schulz A; Bartsch U; Storch S
CNS Drugs; 2019 Apr; 33(4):315-325. PubMed ID: 30877620
[TBL] [Abstract][Full Text] [Related]
3. Progress in the Development of Small Molecule Therapeutics for the Treatment of Neuronal Ceroid Lipofuscinoses (NCLs).
Kinarivala N; Trippier PC
J Med Chem; 2016 May; 59(10):4415-27. PubMed ID: 26565590
[TBL] [Abstract][Full Text] [Related]
4. Clinical challenges and future therapeutic approaches for neuronal ceroid lipofuscinosis.
Mole SE; Anderson G; Band HA; Berkovic SF; Cooper JD; Kleine Holthaus SM; McKay TR; Medina DL; Rahim AA; Schulz A; Smith AJ
Lancet Neurol; 2019 Jan; 18(1):107-116. PubMed ID: 30470609
[TBL] [Abstract][Full Text] [Related]
5. Emerging new roles of the lysosome and neuronal ceroid lipofuscinoses.
Mukherjee AB; Appu AP; Sadhukhan T; Casey S; Mondal A; Zhang Z; Bagh MB
Mol Neurodegener; 2019 Jan; 14(1):4. PubMed ID: 30651094
[TBL] [Abstract][Full Text] [Related]
6. Biochemical aspects of neuronal ceroid lipofuscinoses.
Tyynelä J; Suopanki J
Neurol Sci; 2000; 21(3 Suppl):S21-5. PubMed ID: 11073224
[TBL] [Abstract][Full Text] [Related]
7. Progress in gene and cell therapies for the neuronal ceroid lipofuscinoses.
Donsante A; Boulis NM
Expert Opin Biol Ther; 2018 Jul; 18(7):755-764. PubMed ID: 29936867
[TBL] [Abstract][Full Text] [Related]
8. Treatment of lysosomal storage disorders: focus on the neuronal ceroid-lipofuscinoses.
Pierret C; Morrison JA; Kirk MD
Acta Neurobiol Exp (Wars); 2008; 68(3):429-42. PubMed ID: 18668166
[TBL] [Abstract][Full Text] [Related]
9. Experimental gene therapies for the NCLs.
Liu W; Kleine-Holthaus SM; Herranz-Martin S; Aristorena M; Mole SE; Smith AJ; Ali RR; Rahim AA
Biochim Biophys Acta Mol Basis Dis; 2020 Sep; 1866(9):165772. PubMed ID: 32220628
[TBL] [Abstract][Full Text] [Related]
10. Bioinformatic perspectives in the neuronal ceroid lipofuscinoses.
Kmoch S; Stránecký V; Emes RD; Mitchison HM
Biochim Biophys Acta; 2013 Nov; 1832(11):1831-41. PubMed ID: 23274885
[TBL] [Abstract][Full Text] [Related]
11. Pathomechanisms in the neuronal ceroid lipofuscinoses.
Nelvagal HR; Lange J; Takahashi K; Tarczyluk-Wells MA; Cooper JD
Biochim Biophys Acta Mol Basis Dis; 2020 Sep; 1866(9):165570. PubMed ID: 31678162
[TBL] [Abstract][Full Text] [Related]
12. Moving towards a new era of genomics in the neuronal ceroid lipofuscinoses.
Butz ES; Chandrachud U; Mole SE; Cotman SL
Biochim Biophys Acta Mol Basis Dis; 2020 Sep; 1866(9):165571. PubMed ID: 31678159
[TBL] [Abstract][Full Text] [Related]
13. Intrathecal enzyme replacement therapy improves motor function and survival in a preclinical mouse model of infantile neuronal ceroid lipofuscinosis.
Lu JY; Nelvagal HR; Wang L; Birnbaum SG; Cooper JD; Hofmann SL
Mol Genet Metab; 2015; 116(1-2):98-105. PubMed ID: 25982063
[TBL] [Abstract][Full Text] [Related]
14. Genetic basis and phenotypic correlations of the neuronal ceroid lipofusinoses.
Warrier V; Vieira M; Mole SE
Biochim Biophys Acta; 2013 Nov; 1832(11):1827-30. PubMed ID: 23542453
[TBL] [Abstract][Full Text] [Related]
15. NCL disease mechanisms.
Palmer DN; Barry LA; Tyynelä J; Cooper JD
Biochim Biophys Acta; 2013 Nov; 1832(11):1882-93. PubMed ID: 23707513
[TBL] [Abstract][Full Text] [Related]
16. Towards understanding the neuronal ceroid lipofuscinoses.
Kohlschütter A; Schulz A
Brain Dev; 2009 Aug; 31(7):499-502. PubMed ID: 19195801
[TBL] [Abstract][Full Text] [Related]
17. Batten disease: four genes and still counting.
Mole SE
Neurobiol Dis; 1998 Nov; 5(5):287-303. PubMed ID: 10069573
[TBL] [Abstract][Full Text] [Related]
18. Genetics of the neuronal ceroid lipofuscinoses.
Peltonen L; Savukoski M; Vesa J
Curr Opin Genet Dev; 2000 Jun; 10(3):299-305. PubMed ID: 10826995
[TBL] [Abstract][Full Text] [Related]
19. Recent studies of ovine neuronal ceroid lipofuscinoses from BARN, the Batten Animal Research Network.
Palmer DN; Neverman NJ; Chen JZ; Chang CT; Houweling PJ; Barry LA; Tammen I; Hughes SM; Mitchell NL
Biochim Biophys Acta; 2015 Oct; 1852(10 Pt B):2279-86. PubMed ID: 26073432
[TBL] [Abstract][Full Text] [Related]
20. Neuronal ceroid lipofuscinosis associated with an MFSD8 mutation in Chihuahuas.
Ashwini A; D'Angelo A; Yamato O; Giordano C; Cagnotti G; Harcourt-Brown T; Mhlanga-Mutangadura T; Guo J; Johnson GS; Katz ML
Mol Genet Metab; 2016 Aug; 118(4):326-32. PubMed ID: 27211611
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
